The Top FCA Developments Of 2017
Client Alert | less than 1 min read | 02.02.18
From decisions on small business fraud to interpretations of the reverse FCA, 2017 was another busy year for False Claims Act developments. In a "Feature Comment" published in The Government Contractor, C&M attorneys highlight top developments from 2017 on key issues such as original source requirements, DOJ’s potential dismissal of meritless qui tams, statistical sampling, and perhaps most significantly, the continued evolution of the case law in the wake of the Supreme Court’s landmark implied certification and materiality decision in Escobar.
Contacts
Insights
Client Alert | 5 min read | 03.30.26
The EU Pharma Package: The Transferable Exclusivity Voucher Compromise Proposal
In our third alert in this EU Pharma Package Series, we provided a detailed overview of the diverging positions of the European Commission, the European Parliament , and the Council of the European Union on the transferable exclusivity voucher (TEV) for priority antimicrobials.
Client Alert | 2 min read | 03.27.26
CMS Releases PY 2020 RADV Audit Methods and Instructions: Key Takeaways for Health Plans
Client Alert | 4 min read | 03.25.26
NAIC Intensifies AI Regulatory Focus: What Health Insurance Payors Need to Know
Client Alert | 11 min read | 03.25.26
White House National AI Policy Framework Calls for Preempting State Laws, Protecting Children
